1. Introduction {#s0005}
===============

The natural products from plant origin are safer than the synthetic drug molecules, and are widely recognized in the pharmaceutical industries for their broad structural diversity and the pharmacological activities ([@b0090], [@b0165]). *Coscinium fenestratum* (Goetgh.) Colebr. (*-*commonly known as 'tree turmeric', belongs to the family Menispermaceae), is a medicinally important dioecious threatened liana ([@b0180]), distributed in Vietnam, Singapore, Thailand, Sri Lanka and in isolated regions of the Western Ghats of India ([@b0190]). The stem and root of *C. fenestratum* are used in the traditional system of medicine ([@b0180]). The active chemical berberine (-a natural isoquinoline alkaloid), ceryl alcohol, hentriacontane, palmitic acid, sitosterol, saponin with some resinous material and oleic acid have earlier been reported from *C. fenestratum* ([@b0130]) which possess variety of pharmacological activities including antidiabetic, anti-inflammatory, thermogenic and antiseptic activity ([@b0070]). The free radicals and the other reactive oxygen species (ROS) generated within the living cells as a result of physiological and biochemical processes of the cells causes oxidative damage to the macromolecules of the cells, which lead to liver diseases ([@b0045]), asthma ([@b0085], [@b0015]), cancer ([@b0075]), chronic inflammation, diabetes, multiple sclerosis ([@b0085], [@b0015]), neural disorders ([@b0135]), rheumatoid arthritis ([@b0085], [@b0015]), cardiovascular disease ([@b0155]), Alzheimer disease ([@b0160]), Parkinson's disease ([@b0025]), ulcerative colitis ([@b0120]), and aging ([@b0055]). The free radicals and other reactive oxygen species can be scavenged by the protective role of antioxidants from the natural products of wild and medicinal plants ([@b0115]). Hence, the objective of the present study was to investigate the phytochemical constituents and antioxidant activity of *C. fenestratum*.

2. Materials and methods {#s0010}
========================

2.1. Collection of the plant sample and the preparation of methanolic crude extract {#s0015}
-----------------------------------------------------------------------------------

The fresh leaves of *C. fenestratum* were collected from Velliangiri hills of Western Ghats, Coimbatore, Tamil Nadu, India. The semidry methanolic crude extract \[MeOHCf, test compound\] was prepared from 50 g of shade dried powdered leaves using soxhlet extractor.

2.2. In vitro antioxidant activity {#s0020}
----------------------------------

There are various *in vitro* and *in vivo* methods available for the evaluation of the antioxidant activity of natural products ([@b0005]). The reducing ability ([@b0195]), DPPH radical scavenging activity ([@b0020])*,* the total antioxidant activity ([@b0145]) of MeOHCf were determined using the standard method in order to evaluate the *in vitro* antioxidant activity. One way analysis of variance (ANOVA) test was carried out for statistical analysis using SPSS 10.0.

2.3. Identification of the phytochemical components of MeOHCf by GC--MS analysis {#s0025}
--------------------------------------------------------------------------------

The qualitative phytochemical analysis of MeOHCf for the phytochemicals *viz.,* alkaloids, cardiac glycosides, glycosides, flavonoids, phenols, resins, steroids, saponins, tannins, triterpenoids terpenoids, were performed ([@b0050], [@b0175]). The alkaloid contents of MeOHCf was determined gravimetrically ([@b0095]). The total phenolic and tannin contents of MeOHCf were estimated, and it was expressed as gallic acid equivalents (GAE) mg/g extract ([@b0140]). The content of total flavonoids was determined spectrophotometrically using a standard curve rutin ([@b0200]). MeOHCf was then subjected to the gas chromatography--mass spectrometry (GC--MS) analysis using 5975C Agilent Technologies GC systems equipped with DB-5 ms Agilent fused silica capillary column (30 × 0.25 mm ID, 0.25 μm film thickness) operating with electron impact mode at 70 eV. Finally MeOHCf was assigned for comparison of their retention indices and the mass spectra fragmentation patterns with chemical library of NIST (National Institute of Standards and Technology).

3. Results and discussion {#s0030}
=========================

The percentage yield of MeOHCf was 15.8% w/w. The preliminary phytochemical screening of MeOHCf revealed the presence of flavonoids, saponins and steroids in maximum amount. In addition, the chemical constituents such as alkaloids, terpenoids, triterpenoids, glycosides, cardiac glycosides, phenols, tannins and resins were also present ([Table 1](#t0005){ref-type="table"}). Alkaloids have medicinal importance for the treatment of cancer, CNS disorders, hypertension, inflammation, and malaria ([@b0105]). Phenols have been reported to possess the properties of quenching of oxygen-derived free radicals ([@b0100]). Tannins have been reported to possess a strong astringent properties as well as antimicrobial, anti-inflammatory and antioxidant activity, causing protein precipitation ([@b0185]). Flavonoids increases the capillary permeability and have been used for the treatment of cardiovascular diseases and possess potential antioxidant and anti-inflammatory properties ([@b0035]).Table 1Percentage yield and qualitative phytochemical analysis of MeOHCf.Phytochemical constituentsTraceQualitative phytochemical analysisYield (%)15.8--Alkaloids++Total alkaloids (mg/g of dry powder): 52.00 ± 0.19Flavonoids+++Total flavonoids (mg of QE/g extract): 42.01 ± 0.06Terpenoids++--Triterpenoids++--Glycosides+--Cardiac glycosides+--Phenols++Total phenols (mg of GAE/g extract): 35.11 ± 0.04Saponins+++--Steroids+++--Tannins++Total tannins (mg of GAE/g extract): 34.46 ± 0.02Resins+--[^1]

The spectrum profile of GC--MS was confirmed the presence of a total number of thirty compounds in MeOHCf ([Table 2](#t0010){ref-type="table"}). The prevailing compounds \[the total running time: 40.16 min. ([Fig. 1](#f0005){ref-type="fig"})\] were Bis(2,4,6-triisopropylphenyl) phosphinicazide, a hetrocyclic compound (peak area: 6.70%) ([Fig. 2a](#f0010){ref-type="fig"}), Methyl 2-N-cyclohexylamino-2,3-dideoxy-4,6-o-(phenylmethylene)-3-c-phenylsulfonyl-à,D-glucopyranoside (peak area: 5.99%) ([Fig. 2b](#f0015){ref-type="fig"}), Cyclohexane, 1,4-dimethyl-2-octadecyl- (CAS), an alcohol (peak area: 5.82) ([Fig. 2c](#f0020){ref-type="fig"}) and à-Cyperone, a sesquiterpene (peak area: 5.81) ([Fig. 2d](#f0025){ref-type="fig"}). *C. fenestratum*is endowed with various medicinal properties. Among the identified compounds, EthylN-(p-tolylsulfinyl)(à-trifluoromethyl)-à-allylglycinate was reported to exert anti-proliferative and antitumor activities ([@b0080]). Anti-inflammatory property was shown by compounds 2-Thienylmethylo-(3′-\<t-butyl \> amino-2′-hydroxypropyl) ketoxime, Ethyl N-benzylanthranilate, à-Cyperone and Pyranthrene ([@b0010]). Two compounds *viz.*, Cyclohexane, 1,4-dimethyl-2-octadecyl- (CAS) and 10-\[(3′,5′-Bis(trifluoromethyl)phenyl\]-3-(ethoxycarbonyl methyl)ioalloxazine are reported to have anticancer property ([@b0060]). Aromatic heteropolycyclic compound, 17-(Cyclopropylmethyl)-à-(1′,1′-dimethylethyl) -4,5-epoxy -18,19-dihydro -3-hydroxy -6-methoxy-à-methyl -6,14-ethenomorphinane-7-methanol is a strong opioid antagonist, used as a tranquilizing agent in veterinary medicine ([@b0040]). The compound, 1,5,6, 10b-Tetrahydro-8,9-dimethoxy-10b-(p-methoxyphenyl)-2-methylene- 2H-isoxazolo \[3,2-a\] isoquinoline-1-carbonitrile is used to lower the blood pressure and acts as antihypertensive agent ([@b0110]). In addition, various traditional medicinal plant species of Menispermaceae have been analyzed phytochemically using GC--MS, and suggested for drug preparation after succeeding clinical trials ([@b0030], [@b0125]).Table 2Compounds identified in the MeOHCf by GC--MS.S. no.Name of the compoundRTMolecular formulaMolecular weightPeak area (%)Category of the compoundActivity[a](#tblfn1){ref-type="table-fn"}1.EthylN-(p-tolylsulfinyl)(à-trifluoromethyl)-à-allylglycinate4.16C~15~H**~1~**~8~F~3~NO~3~S3492.56Cyclic compoundAntiproliferative and antitumor properties2.Trimethylester of(4r,5s:4s,5r)-5-(methoxycarbonylmethyl)-1-methyl-2-pyrazolin-3,4,5-tricarbxylic acid4.98C~13~H~18~N~2~O~8~3301.76Hetrocyclic compoundNo activity reported3.2-Thienylmethylo-(3′-\<t-butyl \> amino-2′-hydroxypropyl) ketoxime12.60C~14~H~23~N~2~O~2~S2831.74Hetrocyclic compoundAntiinflammatory activity4.Benzaldehyde, 4-hydroxy-3-methoxy-(CAS)14.11C~8~H~8~O~3~1522.12Phenolic aldehydeAnticonvulsant, antioxidant, antimutagenic agents5.D-friedoolean-14-en-3-one (CAS)21.72C~30~H~48~O4242.41Triterpenoid derivativesAntifungal and antioxidant agents6.Ethyl N-benzylanthranilate22.03C~16~H~17~NO~2~2552.55[Coumarin]{.ul}Antiinflammatory activity7.(E)-á-\[2-hydroxyphenylethylene\]benzeneethanol-D223.38C~15~H~12~D~2~O~2~2261.64--No activity reported8.Himachalol25.23C~15~H~26~O2222.63Sesquiterpene alcoholInsecticidal activity, Antitumor activity9.1,5,6, 10b-Tetrahydro-8,9-dimethoxy-10b-(p-methoxyphenyl)-2-methylene-2H-isoxazolo\[3,2-a\]isoquinoli ne-1-carbonitrile25.64C~22~H~22~N~2~O~4~3781.54[Organic compound]{.ul}Lowers blood pressure, Antihypertensive agent10.1,9-Dimethoxy-10-methyl-2-(carbamoylmethylcarbonyl)-3-(methoxycarbon ylmethyl)-10-methyl-anthracene26.15C~23~H~23~NO~6~4092.82AlkaloidImmunosuppressive agent11.à-Cyperone26.78C~15~H~22~O2185.81SesquiterpeneAntiinflammatory activity12.17-(Cyclopropylmethyl)-à-(1′,1′-dimethylethyl)-4,5- epoxy-18,19-dihydro-3-hydroxy-6-methoxy-à-methyl -6,14-ethenomorphinane-7-methanol27.19C~26~H~35~NO~4~4251.68Aromatic heteropolycyclic compoundStrongest opioid antagonist and used for tranquilizing large animals in veterinary medicine.13.1-P-menthen-8-yl acetate27.74C~12~H~20~O~2~1961.76Aromatic compoundFlavor and fragrance agent14.6-Bromohexanoic acid, 10-undecenyl ester28.51C~17~H~31~BrO~2~3462.54Aliphatic compoundNo activity reported15.2-\[Diacetylamino\]-6-(3′-methyl-5′-oxo-1′-phenyl-2′-pyrazolin-4′-yl)-4-phenylpyridine-3-carbonitrile30.32C~26~H~21~N~5~O~3~4514.80Aliphatic compoundNo activity reported16.Pyranthrene31.02C~30~H~16~3765.16Aromatic compoundAntiinflammatory activity17.Methyl 2-N-cyclohexylamino-2,3-dideoxy-4,6-o-(phenylme thylene)-3-c-phenylsulfonyl-à,D-glucopyranoside31.73C~26~H~32~NO~6~S4865.99--No activity reported18.1-Pyrrolidino-benzoanthra-9,10-quinnone32.03C~22~H~21~NO~2~3312.95Heterocyclic aromatic organic compoundAntibiotic agent19.(22E)-3áAcetoxy- 7.alpha,-hydroperoxystigmasta-5, 22-diene32.69C~31~H~50~O~4~4861.54TriterpenePiscicidal activity20.1-Diphenylphosphino-1-dichlorophosphino-\[1\]-ferrocene33.34C~22~H~18~C~12~FeP~2~4704.24OrganophosphorusNo activity reported21.Bis(2,4,6-triisopropylphenyl)phosphinicazide35.54C~30~H~46~N~3~OP4956.70Hetrocyclic compoundAntitumor and antifolate properties22.6-\[N-(Cyanoamino)\]-3á-methoxymethoxy-cholestane36.62C~30~H~50~N~2~O~2~4703.85AlkaloidAntibiotic agent23.2,3-Bis(3′,4′-dimethoxyphenyl)-5,6-difluorobenzo\[b\]Furan36.96C~24~H~20~F~2~O~5~4264.02Aromatic compoundAntidepressant24.5á-Androst-16-en-3à-ol-\[(t-butyl)dimethylsilyl\] ether37.43C~25~H~44~OSi3882.88Aromatic compoundAntidepressant25.3-(4-Chlorobenzoyl)-7-methyl-2-(2-methylphenylimino)indole38.00C~23~H~19~C~1~N~2~O3744.62OrganochlorineAntifungal and antioxidant properties26.Cyclohexane, 1,4-dimethyl-2-octadecyl- (CAS)38.37C~26~H~52~3645.82AlcoholAnticancer agent27.10-\[(3′,5′-Bis(trifluoromethyl)phenyl\]-3-(ethoxycarbonylmethyl)ioalloxazine38.61C~22~H~14~F~6~N~4~O~4~5122.20Tricyclic compoundAnticancer agent28.13-Docosenamide, (z)-39.00C~22~H~43~NO3374.46Carboxylic acid amideUsed as a detergent, fabric softener, anti-static agent, anti-caking agent, germicide, lubricant, ore floating agent, emulsifier, water treatment agent and insecticide.29.{\[Thorium-(pentamethylcyclopentadienyl)\]-tris\[(trimethylsilylamino)-1′,2′-ethylideneamino\]}39.43C~25~H~54~N~4~Si~3~Th7264.80Aromatic compoundNo activity reported30.Methyl6-deoxy-6-isothiocyanato-2,3,4-tri-o-trimethylsilylà- D-galactopyranoside39.82C~17~H~37~NO~5~Si~3~4512.40Organic compoundNo activity reported[^2]Fig. 1GC--MS chromatogram of methanolic leaf extract of *Coscinium fenestratum.*Fig. 2aMass spectrum of Bis(2,4,6-triisopropylphenyl) phosphinicazid.Fig. 2bMass spectrum of Methyl2-N-cyclohexylamino-2,3-dideoxy-4,6-O-(phenylmethylene) -3-C-phenylsulfonyl-à,D-glucopyranoside.Fig. 2cMass spectrum of Cyclohexane, 1,4-dimethyl-2-octadecyl- (CAS).Fig. 2dMass spectrum of à-Cyperone.

The antioxidants molecules helps in preventing diseases by neutralize the effects of ROS ([@b0150]). The antioxidant property of MeOHCf was determined using various methods. In reducing power assay, MeOHCf displayed significant activity which was found to increase with the increase in the concentration ([Table 3](#t0015){ref-type="table"}) which may serve as significant indicator for the potential antioxidant activity. The results of the resent study were in accordance with the previous reports ([@b0065], [@b0170]). The percentage of scavenging activity on the DPPH radical varies from 32.54% (50 µg/mL of extract) to 64.80% (250 µg/mL of extract). The IC~50~ value of MeOHCf was 182.48 µg/mL ([Table 4](#t0020){ref-type="table"}). The extract showed significant scavenging effect on the DPPH^•^ which was increasing with the increase in the concentration of the sample from 50 to 250 µg/mL, which might be due to abundance of the flavonoid (42 mg of QE/g extract) content, the most required bio compounds for scavenging activity. Similar trend of this activity was also documented previously in our laboratory ([@b0065]). MeOHCf exhibited higher ABTS^•+^ scavenging activity. The 2,2′-azinobis (3-ethylbenzothiazoline sulphonate) radical cation (ABTS^•+^) scavenging activity was 2453.7 µmol trolox equivalent/ g extract ([Table 4](#t0020){ref-type="table"}). This high activity could be due to abundance of secondary metabolites in the plant extracts ([@b0130], [@b0180]).Table 3Reducing power activity of MeOHCf compared with certain standard antioxidants*.*Sample concentration (µg/ ml)Leaf extract (absorbance at 700 nm)Sample concentration (µg/ ml)RutinBHAQuercitinBHT500.610 ± 0.03^a^200.238 ± 0.003^a^0.236 ± 0.016^b^0.359 ± 0.012^a^0.224 ± 0.001^a^1000.645 ± 0.02^a^400.350 ± 0.013^c^0.396 ± 0.017^c^0.632 ± 0.023^b^0.368 ± 0.009^b^1500.723 ± 0.06^b^600.408 ± 0.013^c^0.496 ± 0.028^d^0.718 ± 0.019^c^0.478 ± 0.013^c^2000.816 ± 0.04^c^800.476 ± 0.006^b^0.593 ± 0.008^a^0.833 ± 0.044^d^0.517 ± 0.017^d^2501.060 ± 0.07^d^1000.557 ± 0.014^c^0.644 ± 0.011^b^0.973 ± 0.029^e^0.584 ± 0.012^e^[^3][^4]Table 4DPPH^•^ scavenging activity of MeOHCf compared with certain standard antioxidants.Sample concentration (µg/ mL)% of inhibitionIC~50~ value (µg/mL)Standard antioxidantsIC~50~ value (µg/ mL)5032.54 ± 0.05^a^182.48Rutin15.75 ± 0.0110032.74 ± 0.04^a^Quercetin20.72 ± 0.0515044.21 ± 0.03^b^BHA21.42 ± 0.1120050.09 ± 0.07^bc^BHT34.74 ± 0.2625064.80 ± 0.04^c^[^5][^6]
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[^1]: +: Present, ++: Moderately present, +++: Highly present, GAE: Gallic Acid Equivalent, QE: Quercetin Equivalent. Values were performed in triplicates and represented as mean ± SD.

[^2]: Source: Dr. Duke's Phytochemical and Ethnobotanical Databases.

[^3]: Values were performed in triplicates and represented as mean ± SD.

[^4]: Mean values followed by different superscript in a column are significantly different (p \< 0.05).

[^5]: Values are performed in triplicates and represented as mean ± SD.

[^6]: Mean values followed by different superscripts in a column are significantly different (*p* \< 0.05).
